Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 5 - Drugs for disorders of the endocrine system
Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908)
11/1990
11/15/1990WO1990013643A2 Glycoprotein hormone receptor molecules
11/14/1990EP0396653A1 Recombinant fusion proteins for altering hormone secretion
11/14/1990EP0262188B1 Steroids comprising a spiranic cycle in position 17, preparation process and utilization thereof
11/13/1990US4970205 Sulfonic acid substituted aromatic steroids as inhibitors of steroid 5-α-reductase
11/13/1990CA1276397C Peptide derivatives having a lactonic or cycloaminic structure and process for their preparation
11/07/1990EP0395664A1 Renin inhibitors containing a (1-amino-2-hydroxy-2-heterocyclic) ethyl moiety
11/07/1990CN1010310B Process for preparing agent of anti-hyperlipidemia
11/01/1990WO1990012810A1 Grf analogs viia
10/1990
10/31/1990EP0394429A1 Preparation for transdermal application containing gestodene.
10/31/1990EP0188810B1 Use of dipeptide derivatives for the prevention or treatment of post-traumatic spinal and/or cerebral nerve disorders
10/31/1990CN1046529A Carbostyril derivatives
10/22/1990WO1990012809A1 Novel physiologically active peptide and calcium metabolism-regulating agent comprising said peptide as effective ingredient
10/18/1990WO1990012027A1 Alkyl derivates in 17/21 of 19-nor progesterone
10/18/1990EP0415924A4 Regulation of cell proliferation and differentiation using peptides.
10/17/1990EP0392315A1 Pure Histone H1 for use in therapeutic procedures
10/17/1990CN1046166A Process for preparing 19-nor steroids having in position 11 beta carbonated chain containing amide or carbamate function
10/03/1990EP0390114A2 Suppression of parathyroid hormone synthesis and secretion with vitamin D3 derivatives
10/03/1990EP0389535A1 Renin inhibitors, processes for preparing them, methods for using them, and compositions containing them
09/1990
09/26/1990EP0389180A1 Peptides and their use in therapy
09/26/1990EP0389035A1 Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure (7alpha, 17alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one
09/25/1990US4959390 Polyhydroxybenzyloxypropanolamines
09/20/1990WO1990010620A1 19-nor-vitamin d compounds
09/12/1990EP0387140A1 Composition with an anti-aggregatory effect on blood platelets for therapeutical use
09/11/1990WO1990010462A1 Combination therapy for treatment of estrogen sensitive diseases
09/11/1990WO1990010447A1 Platelet function-inhibiting composition which can be used in therapy
09/04/1990US4954491 Method of treatment using 18-cyanoprogesterone derivatives
09/04/1990US4954490 11 β-substituted progesterone analogs
09/04/1990US4954488 Method of treating hyperaldosteronism using 17β-cyclopropylaminoandrostene derivatives
09/04/1990US4954342 Hypercalocemic agents
08/1990
08/29/1990EP0384842A1 19-Nor steroids substituted at position 11-beta by a hydrocarbon chain containing an amide or carbamate group, their preparation, intermediates, their use as medicaments and pharmaceutical compositions containing them
08/24/1990CA2010826A1 19-nor steroids having an 11-beta substituted carbon chain with an amide or carbamate function, process for their preparation and intermediates therefor, use as medicaments and pharmaceuticasl compositions containing the said steroids
08/23/1990WO1990009194A1 Use of il-7 in providing medications for stimulation of platelet production
08/21/1990US4950659 Antiinflammatory agents
08/16/1990EP0382185A2 Carbostyril derivatives
08/16/1990EP0381747A1 Water soluble branched beta cyclodextrin steroid complex
08/14/1990US4948873 Gonadoliberine analogues of high activity
08/14/1990US4948792 Parenteral administration of cobalt protoporphyrin or cobalt mesoporphyrin
08/14/1990US4948789 Suppression of parathyroid hormone synthesis and secretion
08/01/1990EP0380355A2 Carbamates of 6-chloro-7,8-dihydroxy-1-(4'-Hydroxyphenyl)-2,3,4,5-tetra-hydro-1H-3-benzazepine as prodrugs
08/01/1990EP0380135A2 Use of 18-cyano-progesterone derivatives as aldosterone inhibitors
07/1990
07/26/1990WO1990006949A3 Peptide derivatives
07/17/1990US4942158 Drug delivery patch for steroid delivery through skin
07/11/1990EP0281608B1 Hydroxylindol derivatives
07/10/1990CA1271600A1 Growth hormone-releasing peptides and method of treating mammals therewith
07/03/1990CA1271299A1 Synthetic analogs of growth hormone releasing factor
06/1990
06/28/1990WO1990006950A1 Recombinant dna molecules, hosts, processes and human somatomedin carrier protein-like polypeptides
06/28/1990WO1990006949A2 Peptide derivatives
06/27/1990EP0375559A1 Steroids containing an alkythio radical at position 4, process for their preparation, their use as medicaments and pharmaceutical compositions containing them
06/27/1990EP0375438A2 Recombinant DNA molecules, hosts, processes and human somatomedin carrier protein-like polypeptides
06/27/1990EP0375347A1 Sulphonic acid substituted aromatic steroids as inhibitors of steroid 5-alpha-reductase
06/27/1990EP0375344A1 Phosphinic acid substituted aromatic steroids as inhibitors of steroid 5alpha-reductase
06/26/1990US4937237 Phosphinic acid substituted aromatic steroids as inhibitors of steroid 5-60 -reductase
06/26/1990CA1270762A1 Pharmaceutical composition comprising a derivative of maleopiramic acid
06/23/1990CA2005215A1 Sulfonic acid substituted aromatic steroids as inhibitors of steroid 5–-reductase
06/23/1990CA2004945A1 Phosphinic acid substituted aromatic steroids as inhibitors of steroid 5–-reductase
06/20/1990EP0373593A2 Acyloxypropanolamines
06/20/1990EP0373591A2 Polyhydroxybenzyloxypropanolamines
06/20/1990EP0373545A2 Competitive genadoliberin antagonists
06/19/1990US4935422 Acyloxypropanolamines
06/15/1990CA2005374A1 Polyhydroxybenzylpxypropanolamines
06/15/1990CA2005372A1 Acyloxypropanolamines
06/13/1990EP0140084B1 Process for the preparation of insulin derivatives with a c-terminally elongated b-chain, basically modified insulin derivatives, compositions containing them and their use
06/13/1990CN1042912A (1h-azol-1-ylmethyl) substituted quinoline, quinazoline or quinoxaline derivatives
06/06/1990EP0371564A2 (1H-azol-1-ylmethyl)substituted quinoline, quinazoline or quinoxaline derivatives
06/06/1990EP0371559A2 Use of benzimidazoles in the treatment of epithelial disorders
06/06/1990EP0371390A2 Amino acid derivatives
05/1990
05/31/1990CA2004001A1 Amino acid derivatives
05/30/1990EP0370220A1 Gestode composition for transdermal application
05/22/1990CA1269498A1 Enzyme-resistant immunomodulatory peptides
05/16/1990CN1042075A Medicines for transcortical application containing steroidhormonen
05/09/1990EP0367576A2 Estrogen nucleus derivatives for use in the inhibition of sex steroid activity
05/09/1990EP0367554A2 Insulin binders and inhibitors of insulin binding
05/09/1990EP0367431A1 Novel composition for skin penetration enhancement
05/09/1990EP0366669A1 Malic acid derivative containing renin inhibiting peptides
05/08/1990US4923805 Culturing cells capable of glycosylating proteins; gene expression dimerization
05/08/1990CA1268899A1 Cyclic hexapeptide somatostatin analogs
05/08/1990CA1268898A1 Growth hormone-releasing peptides and method of treating mammals therewith
05/08/1990CA1268897A1 Gonadoliberin derivatives and process for the preparation thereof
05/03/1990WO1990004788A1 Method for identifying active domains and amino acid residues in polypeptides and hormone variants
05/03/1990WO1990004403A1 Treatment of hypertension
05/03/1990WO1990004402A1 Treatment of osteoporosis
05/03/1990WO1990004397A1 Preparation for transdermal application containing gestodene
05/02/1990EP0366609A2 Use of bicyclic imidazole derivatives in treating hyperaldosteronism
05/01/1990CA1268597A1 Diamino acid derivatives
04/1990
04/30/1990CA2001938A1 Estrogen nucleus derivatives for use in the inhibition of sex steroid activity
04/28/1990CA2345497A1 Growth hormone variants and method for forming growth hormone variants
04/26/1990CA2001301A1 Use of bicyclic imidazole compounds for the treatment of hyperaldosteronism
04/25/1990CN1041528A Hormone preparation and method
04/19/1990WO1990003980A1 Therapeutic peptides
04/17/1990CA1267999A1 Nonapeptide and decapeptide analogs of lhrh, useful as lhrh agonist
04/17/1990CA1267995A1 Biologically active peptides structurally related to regions within growth hormones
04/17/1990CA1267888A1 6,6-ETHYLENE-15,16-METHYLENE-3-OXO-17.alpha.-PREGN-4-ENE- 21,17-CARBOLACTONES, PROCESSES FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM
04/11/1990EP0363128A2 Anti-androgen compounds
04/05/1990WO1990003385A1 11β-PHENYL-14βH-STEROIDS
04/04/1990CN1040981A 三环化合物 Tricyclic compounds
04/03/1990US4914089 Pharmaceutical dosage unit
04/03/1990US4913852 Antiinflammatory agents
04/03/1990CA1267408A1 Griseolic acid derivatives, and their use
03/1990
03/28/1990EP0360369A1 11-Beta-phenyl-14-beta-H-steroids
03/28/1990EP0360079A1 Tricyclic compounds, processes for their preparation and pharmaceutical compositions comprising them
1 ... 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290